These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 31559544)
1. The Tyrer-Cuzick Model Inaccurately Predicts Invasive Breast Cancer Risk in Women With LCIS. Valero MG; Zabor EC; Park A; Gilbert E; Newman A; King TA; Pilewskie ML Ann Surg Oncol; 2020 Mar; 27(3):736-740. PubMed ID: 31559544 [TBL] [Abstract][Full Text] [Related]
2. Accuracy of the Breast Cancer Surveillance Consortium Model Among Women with LCIS. Eroglu I; Sevilimedu V; Park A; King TA; Pilewskie ML Breast Cancer Res Treat; 2022 Jul; 194(2):257-264. PubMed ID: 35595928 [TBL] [Abstract][Full Text] [Related]
3. Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density. Brentnall AR; Cuzick J; Buist DSM; Bowles EJA JAMA Oncol; 2018 Sep; 4(9):e180174. PubMed ID: 29621362 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia. Boughey JC; Hartmann LC; Anderson SS; Degnim AC; Vierkant RA; Reynolds CA; Frost MH; Pankratz VS J Clin Oncol; 2010 Aug; 28(22):3591-6. PubMed ID: 20606088 [TBL] [Abstract][Full Text] [Related]
5. Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In Situ. Nakhlis F; Harrison BT; Giess CS; Lester SC; Hughes KS; Coopey SB; King TA Ann Surg Oncol; 2019 Jan; 26(1):55-61. PubMed ID: 30362065 [TBL] [Abstract][Full Text] [Related]
6. Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative. Kurian AW; Hughes E; Simmons T; Bernhisel R; Probst B; Meek S; Caswell-Jin JL; John EM; Lanchbury JS; Slavin TP; Wagner S; Gutin A; Rohan TE; Shadyab AH; Manson JE; Lane D; Chlebowski RT; Stefanick ML Cancer; 2021 Oct; 127(20):3742-3750. PubMed ID: 34228814 [TBL] [Abstract][Full Text] [Related]
7. Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review. De Brot M; Koslow Mautner S; Muhsen S; Andrade VP; Mamtani A; Murray M; Giri D; Sakr RA; Brogi E; King TA Breast Cancer Res Treat; 2017 Sep; 165(2):411-420. PubMed ID: 28612228 [TBL] [Abstract][Full Text] [Related]
8. ASO Author Reflections: Breast Cancer Risk Assessment in Women with LCIS-More Work Is Needed. Valero MG; King TA; Pilewskie ML Ann Surg Oncol; 2020 Mar; 27(3):741-742. PubMed ID: 31863418 [No Abstract] [Full Text] [Related]
9. Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk. King TA; Pilewskie M; Muhsen S; Patil S; Mautner SK; Park A; Oskar S; Guerini-Rocco E; Boafo C; Gooch JC; De Brot M; Reis-Filho JS; Morrogh M; Andrade VP; Sakr RA; Morrow M J Clin Oncol; 2015 Nov; 33(33):3945-52. PubMed ID: 26371145 [TBL] [Abstract][Full Text] [Related]
10. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Page DL; Kidd TE; Dupont WD; Simpson JF; Rogers LW Hum Pathol; 1991 Dec; 22(12):1232-9. PubMed ID: 1748429 [TBL] [Abstract][Full Text] [Related]
11. Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort. Brentnall AR; Harkness EF; Astley SM; Donnelly LS; Stavrinos P; Sampson S; Fox L; Sergeant JC; Harvie MN; Wilson M; Beetles U; Gadde S; Lim Y; Jain A; Bundred S; Barr N; Reece V; Howell A; Cuzick J; Evans DG Breast Cancer Res; 2015 Dec; 17(1):147. PubMed ID: 26627479 [TBL] [Abstract][Full Text] [Related]
12. Use of Receiver Operating Characteristic (ROC) Curve Analysis for Tyrer-Cuzick and Gail in Breast Cancer Screening in Jiangxi Province, China. Zhang L; Jie Z; Xu S; Zhang L; Guo X Med Sci Monit; 2018 Aug; 24():5528-5532. PubMed ID: 30089770 [TBL] [Abstract][Full Text] [Related]
13. Do Body Mass Index and Breast Density Impact Cancer Risk Among Women with Lobular Carcinoma In Situ? Minami CA; Zabor EC; Gilbert E; Newman A; Park A; Jochelson MS; King TA; Pilewskie ML Ann Surg Oncol; 2020 Jun; 27(6):1844-1851. PubMed ID: 31898097 [TBL] [Abstract][Full Text] [Related]
14. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies. Renshaw AA; Gould EW Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205 [TBL] [Abstract][Full Text] [Related]
15. The Pathologic Finding of Combined Lobular Carcinoma Jean-Louis CJ; Masdon J; Smith B; Battles O; Dale P Am Surg; 2017 May; 83(5):482-485. PubMed ID: 28541858 [TBL] [Abstract][Full Text] [Related]
16. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ. Wong SM; King T; Boileau JF; Barry WT; Golshan M Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673 [TBL] [Abstract][Full Text] [Related]
17. Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry. Pal Choudhury P; Brook MN; Hurson AN; Lee A; Mulder CV; Coulson P; Schoemaker MJ; Jones ME; Swerdlow AJ; Chatterjee N; Antoniou AC; Garcia-Closas M Breast Cancer Res; 2021 Feb; 23(1):22. PubMed ID: 33588869 [TBL] [Abstract][Full Text] [Related]
18. Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma Trivedi MS; Coe AM; Vanegas A; Kukafka R; Crew KD Cancer Prev Res (Phila); 2017 Aug; 10(8):434-441. PubMed ID: 28611039 [TBL] [Abstract][Full Text] [Related]
19. Risk of Contralateral Breast Cancer in Women with Ductal Carcinoma In Situ Associated with Synchronous Ipsilateral Lobular Carcinoma In Situ. Miller ME; Muhsen S; Zabor EC; Flynn J; Olcese C; Giri D; Van Zee KJ; Pilewskie M Ann Surg Oncol; 2019 Dec; 26(13):4317-4325. PubMed ID: 31552614 [TBL] [Abstract][Full Text] [Related]
20. The morphologic spectrum of lobular carcinoma in situ (LCIS) observations on clinical significance, management implications and diagnostic pitfalls of classic, florid and pleomorphic LCIS. Brogi E Virchows Arch; 2022 Dec; 481(6):823-837. PubMed ID: 35567633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]